PDCD1 and neoplasm: Moreover, high levels of IFNγ, produced also by activated NK cells, induced the expression of PD-L1 on tumor cells [73,76], which could sensitize PD-L1− tumor to PD-1-PD-L1 checkpoint inhibitor therapies.